Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study

Phase: N/A Priority: Normal
NCT ID: NCT06350474 Org: User:
Start: 08/25/20 End: 07/11/22 Due: 07/11/23

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Phase: N/A Priority: Normal
NCT ID: NCT06504589 Org: User:
Start: 09/18/24 End: 08/14/29 Due: 08/14/30

The PROMISE Pediatric Study 6 to 11 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT04613128 Org: User:
Start: 06/11/21 End: 12/19/25 Due: 12/19/26

A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function

Phase: N/A Priority: Normal
NCT ID: NCT04038047 Org: User:
Start: 10/22/19 End: 12/23/24 Due: 12/23/25

CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03350828 Org: User:
Start: 01/15/18 End: 12/31/26 Due: 12/31/27

Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04378153 Org: User:
Start: 08/25/20 End: 07/11/22 Due: 07/11/23

Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study

Phase: N/A Priority: Normal
NCT ID: NCT06350461 Org: User:
Start: 08/25/20 End: 07/11/22 Due: 07/11/23